Cite

    Katarzyna Jabbour et al.. “Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?.” Evidence-based practice, vol. 21, no. 9, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100123023224.0x000006